Kirkland Represents The Carlyle Group on Acquisition of Unchained Labs for $435 Million

Kirkland & Ellis advised The Carlyle Group (NASDAQ:CG), a global investment firm, on its acquisition of Unchained Labs, a rapidly growing life science tools company, for $435 million in partnership with its management team, from Novo Holdings A/S, Canaan Partners and TPG Biotech. The transaction is subject to regulatory approvals and is expected to close in Q2 2021.

Read the Unchained Labs press release

The Kirkland team was led by corporate partners Shawn OHargan and Eunu Chun and associates Jaye Kasper, Philippe Simard and Bridget Hamway.